Rosuvastatin

Generic name: Pronounced as (roe soo'' va stat' in)
Brand names
  • Crestor®
  • Ezallor®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2020

[Posted 07/20/2021]

AUDIENCE: Patient, Health Professional, OBGYN, Cardiology, Endocrinology, Pharmacy

ISSUE: The FDA is requesting revisions to the information about use in pregnancy in the prescribing information of the entire class of statin medicines. These changes include removing the contraindication against using these medicines in all pregnant patients. A contraindication is FDA's strongest warning and is only added when a medicine should not be used because the risk clearly outweighs any possible benefit. Because the benefits of statins may include prevention of serious or potentially fatal events in a small group of very high-risk pregnant patients, contraindicating these drugs in all pregnant women is not appropriate.

FDA expects removing the contraindication will enable health care professionals and patients to make individual decisions about benefit and risk, especially for those at very high risk of heart attack or stroke. This includes patients with homozygous familial hypercholesterolemia and those who have previously had a heart attack or stroke.

BACKGROUND: Statins are a class of prescription medicines that have been used for decades to lower low-density lipoprotein (LDL-C or "bad") cholesterol in the blood. Medicines in the statin class include atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin.

RECOMMENDATIONS:

  • Patients: Patients taking statins should notify their health care professionals if they become pregnant or suspect they are pregnant. Your health care professional will be able to advise whether you should stop taking the medicine during pregnancy and whether you may stop your statin temporarily while breastfeeding. Patients who are at high risk of heart attack or stroke who require statins after giving birth should not breastfeed and should use alternatives such as infant formula.

  • Health Care Professionals: Health care professionals should discontinue statin therapy in most pregnant patients, or they can consider the ongoing therapeutic needs of the individual patient, particularly those at very high risk for cardiovascular events during pregnancy. Because of the chronic nature of cardiovascular disease, treatment of hyperlipidemia is not generally necessary during pregnancy. Discuss with patients whether they may discontinue statins temporarily while breastfeeding. Advise those who require a statin because of their cardiovascular risk that breastfeeding is not recommended because the medicine may pass into breast milk

The FDA hopes the revised language in the prescribing information will help reassure health care professionals that statins are safe to prescribe in patients who can become pregnant, and help them reassure patients with unintended statin exposure in early pregnancy or before pregnancy is recognized that the medicine is unlikely to harm the unborn baby.

For more information visit the FDA website at: http://www.fda.gov/Safety/MedWatch/SafetyInformation and http://www.fda.gov/Drugs/DrugSafety.

Rosuvastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Rosuvastatin is also used to decrease the amount of cholesterol such as low-density lipoprotein (LDL) cholesterol ('bad cholesterol') and triglycerides in the blood and to increase the amount of high-density lipoprotein (HDL) cholesterol ('good cholesterol') in the blood. Rosuvastatin may also be used together with diet to decrease the amount of cholesterol and other fatty substances in the blood in children and teenagers 8 to 17 years of age who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally). Rosuvastatin is used together with diet, and alone or in combination with other medications, to decrease the amount of cholesterol and other fatty substances in the blood in adults and children and teenagers 7 to 17 years of age who have familial homozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally). Rosuvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.

Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with rosuvastatin has been shown to prevent heart disease, angina (chest pain), strokes, and heart attacks.

Rosuvastatin comes as a tablet (Crestor) to take by mouth. Rosuvastatin also comes as a capsule (Ezallor) to take by mouth or to open, mix with water, and give through a feeding tube. It is usually taken once a day with or without food. Take rosuvastatin at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take rosuvastatin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of rosuvastatin and gradually increase your dose, not more than once every 2 to 4 weeks.

Swallow the capsules (Ezallor) whole; do not chew or crush them. If you cannot swallow the capsule, open the capsule and carefully sprinkle the contents onto 1 teaspoonful of applesauce. Swallow the entire mixture immediately without chewing. Do not save the applesauce mixture for later use.

Continue to take rosuvastatin even if you feel well. Do not stop taking rosuvastatin without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking rosuvastatin,

  • tell your doctor and pharmacist if you are allergic to rosuvastatin, any other medications, or any of the ingredients in rosuvastatin tablets or capsules. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); colchicine (Colcrys); cimetidine (Tagamet); cyclosporine (Gengraf, Neoral, Sandimmune); darolutamide (Nubeqa); eltrombopag (Promacta); ketoconazole (Nizoral); other medications for high cholesterol such as fenofibrate (Tricor), gemfibrozil (Lopid), and niacin (Niaspan, Niacor); certain hepatitis C virus (HCV) medications including dasabuvir taken with ombitasvir, paritaprevir, and ritonavir (Viekira Pak); glecaprevir taken with pibrentasvir (Mavyret), ledipasvir taken with sofosbuvir (Harvoni), simeprevir (no longer available in US), or sofosbuvir taken with velpatasvir and/or voxilaprevir (Epclusa, Vosevi); certain HIV protease inhibitors including atazanavir (Reyataz) taken with ritonavir (Norvir), and lopinavir and ritonavir (Kaletra); regorafenib (Stivarga); and spironolactone (Aldactone). Many other medications may also interact with rosuvastatin, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking aluminum and magnesium hydroxide antacids (Mylanta, Maalox), take them at least 2 hours after rosuvastatin.

  • tell your doctor if you have liver disease. Your doctor will order laboratory tests to see how well your liver is working even if you do not think you have liver disease. Your doctor will probably tell you not to take rosuvastatin if you have liver disease or if the tests show that you may be developing liver disease.

  • tell your doctor if you are Asian, if you drink more than 2 alcoholic beverages daily, if you are 65 years of age or older, if you have ever had liver disease, or if you have or have ever had seizures, muscle aches or weakness, low blood pressure, or kidney or thyroid disease.

  • tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while you are taking rosuvastatin. Talk to your doctor about birth control methods that you can use during your treatment. If you become pregnant while taking rosuvastatin, call your doctor immediately. Rosuvastatin may harm the fetus.

  • do not breastfeed while taking rosuvastatin.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking rosuvastatin. If you are hospitalized due to serious injury or infection, tell the doctor who treats you that you are taking rosuvastatin.

  • ask your doctor about the safe use of alcoholic beverages while you are taking rosuvastatin. Alcohol can increase the risk of serious side effects.

Eat a low-fat, low-cholesterol diet. Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. You can also visit the National Cholesterol Education Program (NCEP) website for additional dietary information at http://www.nhlbi.nih.gov/health/public/heart/chol/chol_tlc.pdf.

Take the missed dose as soon as you remember it. However, if it is less than 12 hours before your next dose is scheduled, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Rosuvastatin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • constipation

    • stomach pain

    • dizziness

    • difficulty falling asleep or staying asleep

    • depression

    • joint pain

    • headache

    • memory loss or forgetfulness

    • confusion

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical help:

    • muscle pain, tenderness, or weakness (or if these symptoms continue after stopping rosuvastatin)

    • lack of energy

    • fever

    • chest pain

    • dark, reddish urine; decreased amount of urine; weakness; and muscle aches

    • yellowing of the skin or eyes

    • dark colored urine

    • pain in the upper right part of the abdomen

    • nausea

    • extreme tiredness

    • weakness

    • unusual bleeding or bruising

    • loss of appetite

    • flu-like symptoms

    • rash

    • hives

    • itching

    • difficulty breathing or swallowing

    • swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs

    • hoarseness

  • Rosuvastatin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor may order lab tests during your treatment, especially if you develop symptoms of liver damage.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking rosuvastatin.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Rosuvastatin.
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Rosuvastatin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosuvastatin.
Leflunomide Leflunomide The serum concentration of Rosuvastatin can be increased when it is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Rosuvastatin can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Rosuvastatin can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin Atorvastatin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Alendronate Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Rosuvastatin.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Rosuvastatin.
Calcium Carbonate Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candesartan Candesartan The excretion of Rosuvastatin can be decreased when combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Rosuvastatin.
Clopidogrel Clopidogrel The metabolism of Rosuvastatin can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Rosuvastatin can be decreased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The excretion of Rosuvastatin can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylergonovine Methylergonovine The metabolism of Rosuvastatin can be decreased when combined with Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Rosuvastatin.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Rosuvastatin.
Ranitidine Ranitidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Rosuvastatin.
Reserpine Reserpine Reserpine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Sumatriptan Sumatriptan The excretion of Rosuvastatin can be decreased when combined with Sumatriptan.
Tacrolimus Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Rosuvastatin.
Triamcinolone Triamcinolone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Rosuvastatin.
Doxycycline Injection Doxycycline Injection The metabolism of Rosuvastatin can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The excretion of Rosuvastatin can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection The metabolism of Fluconazole can be decreased when combined with Rosuvastatin.
Hydromorphone Injection Hydromorphone Injection The metabolism of Rosuvastatin can be decreased when combined with Hydromorphone.
Meperidine Injection Meperidine Injection The metabolism of Rosuvastatin can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Rosuvastatin can be increased when combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Rosuvastatin can be decreased when combined with Metronidazole.
Pamidronate Injection Pamidronate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Rosuvastatin.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Rosuvastatin.
Cyclosporine Cyclosporine The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Rosuvastatin can be decreased when combined with Ondansetron.
Torsemide Torsemide The metabolism of Rosuvastatin can be decreased when combined with Torasemide.
Olanzapine Olanzapine The metabolism of Rosuvastatin can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Rosuvastatin can be decreased when combined with Alosetron.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Rosuvastatin.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Rosuvastatin.
Meloxicam Meloxicam The metabolism of Rosuvastatin can be decreased when combined with Meloxicam.
Orlistat Orlistat The metabolism of Rosuvastatin can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Rosuvastatin can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Risedronate Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Rosuvastatin.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Zaleplon Zaleplon The metabolism of Rosuvastatin can be decreased when combined with Zaleplon.
Anakinra Anakinra The metabolism of Rosuvastatin can be increased when combined with Anakinra.
Trimipramine Trimipramine The metabolism of Rosuvastatin can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Rosuvastatin can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Rosuvastatin can be increased when combined with Modafinil.
Tenofovir Tenofovir The excretion of Tenofovir can be decreased when combined with Rosuvastatin.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Rosuvastatin.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Rosuvastatin.
Epinephrine Injection Epinephrine Injection The metabolism of Rosuvastatin can be decreased when combined with Epinephrine.
Eplerenone Eplerenone The metabolism of Rosuvastatin can be decreased when combined with Eplerenone.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Zonisamide Zonisamide The metabolism of Rosuvastatin can be decreased when combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Rosuvastatin can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Rosuvastatin.
Ezetimibe Ezetimibe Rosuvastatin may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Atazanavir Atazanavir The serum concentration of Rosuvastatin can be increased when it is combined with Atazanavir.
Eletriptan Eletriptan The metabolism of Rosuvastatin can be decreased when combined with Eletriptan.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Rosuvastatin can be decreased when combined with Vardenafil.
Aprepitant Aprepitant The metabolism of Rosuvastatin can be decreased when combined with Aprepitant.
Tadalafil Tadalafil The metabolism of Rosuvastatin can be decreased when combined with Tadalafil.
Fosamprenavir Fosamprenavir The serum concentration of Rosuvastatin can be increased when it is combined with Fosamprenavir.
Progesterone Progesterone Progesterone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The metabolism of Rosuvastatin can be decreased when combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Rosuvastatin can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Rosuvastatin can be decreased when combined with Oxandrolone.
Rifaximin Rifaximin The metabolism of Rosuvastatin can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Rosuvastatin can be decreased when combined with Duloxetine.
Norethindrone Norethindrone Norethisterone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Bosentan Bosentan The serum concentration of Rosuvastatin can be decreased when it is combined with Bosentan.
Cefditoren Cefditoren The excretion of Cefdinir can be decreased when combined with Rosuvastatin.
Erlotinib Erlotinib The metabolism of Rosuvastatin can be decreased when combined with Erlotinib.
Ganciclovir Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Rosuvastatin.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Rosuvastatin.
Voriconazole Voriconazole The metabolism of Rosuvastatin can be decreased when combined with Voriconazole.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The metabolism of Rosuvastatin can be increased when combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Rosuvastatin.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Rosuvastatin.
Ibandronate Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Rosuvastatin.
Ramelteon Ramelteon The metabolism of Rosuvastatin can be decreased when combined with Ramelteon.
Fentanyl Fentanyl The metabolism of Rosuvastatin can be decreased when combined with Fentanyl.
Deferasirox Deferasirox The metabolism of Rosuvastatin can be increased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Rosuvastatin can be increased when it is combined with Tipranavir.
Felbamate Felbamate The metabolism of Rosuvastatin can be decreased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Rosuvastatin.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Rosuvastatin can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Rosuvastatin can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Rosuvastatin.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Rosuvastatin.
Bortezomib Bortezomib The metabolism of Rosuvastatin can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The excretion of Clofarabine can be decreased when combined with Rosuvastatin.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Rosuvastatin.
Posaconazole Posaconazole The metabolism of Rosuvastatin can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Rosuvastatin can be decreased when combined with Primaquine.
Darunavir Darunavir The serum concentration of Rosuvastatin can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The excretion of Pemetrexed can be decreased when combined with Rosuvastatin.
Nabilone Nabilone The metabolism of Rosuvastatin can be decreased when combined with Nabilone.
Sorafenib Sorafenib The metabolism of Rosuvastatin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Rosuvastatin.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Rosuvastatin.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Rosuvastatin.
Armodafinil Armodafinil The metabolism of Rosuvastatin can be increased when combined with Armodafinil.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Rosuvastatin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Rosuvastatin.
Nilotinib Nilotinib The metabolism of Rosuvastatin can be decreased when combined with Nilotinib.
Raltegravir Raltegravir The risk or severity of myopathy and rhabdomyolysis can be increased when Raltegravir is combined with Rosuvastatin.
Bexarotene Bexarotene The metabolism of Rosuvastatin can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Rosuvastatin can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Rosuvastatin can be decreased when combined with Chloramphenicol.
Doripenem Injection Doripenem Injection The excretion of Doripenem can be decreased when combined with Rosuvastatin.
Etravirine Etravirine The metabolism of Rosuvastatin can be increased when combined with Etravirine.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Rosuvastatin can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Rosuvastatin can be decreased when combined with Desvenlafaxine.
Tretinoin Tretinoin The metabolism of Rosuvastatin can be decreased when combined with Tretinoin.
Leucovorin Injection Leucovorin Injection The excretion of Rosuvastatin can be decreased when combined with Leucovorin.
Pilocarpine Pilocarpine The metabolism of Rosuvastatin can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Rosuvastatin can be decreased when combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Rosuvastatin can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Rosuvastatin.
Irinotecan Injection Irinotecan Injection The metabolism of Rosuvastatin can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection The risk or severity of myopathy can be increased when Rosuvastatin is combined with Daptomycin.
Praziquantel Praziquantel The metabolism of Rosuvastatin can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Rosuvastatin can be increased when combined with Mitotane.
Rufinamide Rufinamide The metabolism of Rosuvastatin can be increased when combined with Rufinamide.
Midazolam Midazolam The metabolism of Rosuvastatin can be decreased when combined with Midazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Rosuvastatin.
Eltrombopag Eltrombopag The serum concentration of Rosuvastatin can be increased when it is combined with Eltrombopag.
Milnacipran Milnacipran The metabolism of Rosuvastatin can be decreased when combined with Milnacipran.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Rosuvastatin.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Rosuvastatin.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Rosuvastatin.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Rosuvastatin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Rosuvastatin.
Dronedarone Dronedarone The serum concentration of Rosuvastatin can be increased when it is combined with Dronedarone.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Rosuvastatin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Rosuvastatin.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Rosuvastatin.
Topotecan Topotecan The metabolism of Rosuvastatin can be increased when combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Rosuvastatin can be increased when combined with Golimumab.
Pazopanib Pazopanib Rosuvastatin may increase the hepatotoxic activities of Pazopanib.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Pitavastatin.
Albendazole Albendazole The metabolism of Rosuvastatin can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel Levonorgestrel may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Rosuvastatin.
Tocilizumab Injection Tocilizumab Injection The metabolism of Rosuvastatin can be increased when combined with Tocilizumab.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Rosuvastatin can be decreased when combined with Cabazitaxel.
Acetaminophen Injection Acetaminophen Injection The metabolism of Rosuvastatin can be increased when combined with Acetaminophen.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Rosuvastatin can be decreased when combined with Aldesleukin.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Rosuvastatin.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Rosuvastatin.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Rosuvastatin.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Telaprevir Telaprevir Glecaprevir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Rosuvastatin can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Rosuvastatin can be decreased when combined with Abiraterone.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Rosuvastatin.
Ticagrelor Ticagrelor The metabolism of Rosuvastatin can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Rosuvastatin can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Rosuvastatin.
Vandetanib Vandetanib The metabolism of Rosuvastatin can be decreased when combined with Vandetanib.
Clobazam Clobazam The metabolism of Rosuvastatin can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The metabolism of Rosuvastatin can be decreased when combined with Vemurafenib.
Vismodegib Vismodegib Vismodegib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Rosuvastatin.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Rosuvastatin.
Crizotinib Crizotinib The metabolism of Rosuvastatin can be decreased when combined with Crizotinib.
Cabergoline Cabergoline The metabolism of Rosuvastatin can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Rosuvastatin can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Rosuvastatin.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Rosuvastatin.
Enzalutamide Enzalutamide The metabolism of Rosuvastatin can be increased when combined with Enzalutamide.
Regorafenib Regorafenib The metabolism of Rosuvastatin can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Rosuvastatin can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Rosuvastatin can be increased when combined with Corticotropin.
Teriflunomide Teriflunomide The serum concentration of Rosuvastatin can be increased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Rosuvastatin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Rosuvastatin.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Rosuvastatin.
Ponatinib Ponatinib The metabolism of Rosuvastatin can be decreased when combined with Ponatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Rosuvastatin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Rosuvastatin can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Rosuvastatin.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Rosuvastatin.
Dabrafenib Dabrafenib The metabolism of Rosuvastatin can be increased when combined with Dabrafenib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Rosuvastatin.
Trametinib Trametinib The metabolism of Rosuvastatin can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.
Afatinib Afatinib Afatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Rosuvastatin.
Perampanel Perampanel The metabolism of Rosuvastatin can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Rosuvastatin.
Lomitapide Lomitapide The metabolism of Rosuvastatin can be decreased when combined with Lomitapide.
Ketorolac Injection Ketorolac Injection The metabolism of Rosuvastatin can be decreased when combined with Ketorolac.
Simeprevir Simeprevir The serum concentration of Rosuvastatin can be increased when it is combined with Simeprevir.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Rosuvastatin.
Apremilast Apremilast The metabolism of Rosuvastatin can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Rosuvastatin can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Rosuvastatin can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Rosuvastatin.
Eslicarbazepine Eslicarbazepine The metabolism of Rosuvastatin can be increased when combined with Eslicarbazepine.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Rosuvastatin.
Testosterone Injection Testosterone Injection The metabolism of Rosuvastatin can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Rosuvastatin can be increased when combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Rosuvastatin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Rosuvastatin.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Rosuvastatin.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Rosuvastatin.
Olaparib Olaparib The metabolism of Rosuvastatin can be decreased when combined with Olaparib.
Caspofungin Injection Caspofungin Injection The excretion of Rosuvastatin can be decreased when combined with Caspofungin.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Rosuvastatin.
Lanreotide Injection Lanreotide Injection The metabolism of Rosuvastatin can be decreased when combined with Lanreotide.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Rosuvastatin.
Secukinumab Injection Secukinumab Injection The metabolism of Rosuvastatin can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Rosuvastatin can be decreased when combined with Risperidone.
Palbociclib Palbociclib The metabolism of Rosuvastatin can be decreased when combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Rosuvastatin.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Rosuvastatin.
Haloperidol Injection Haloperidol Injection The serum concentration of Rosuvastatin can be increased when it is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Rosuvastatin which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Rosuvastatin can be increased when combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Rosuvastatin.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Prednisolone Prednisolone The metabolism of Rosuvastatin can be increased when combined with Prednisolone.
Daclatasvir Daclatasvir The serum concentration of Rosuvastatin can be increased when it is combined with Daclatasvir.
Ziprasidone Injection Ziprasidone Injection The metabolism of Rosuvastatin can be decreased when combined with Ziprasidone.
Eluxadoline Eluxadoline The serum concentration of Rosuvastatin can be increased when it is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Rosuvastatin.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Rosuvastatin.
Trabectedin Injection Trabectedin Injection The risk or severity of myopathy and rhabdomyolysis can be increased when Rosuvastatin is combined with Trabectedin.
Osimertinib Osimertinib The metabolism of Rosuvastatin can be decreased when combined with Osimertinib.
Alectinib Alectinib The metabolism of Rosuvastatin can be decreased when combined with Alectinib.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Rosuvastatin.
Rifapentine Rifapentine The metabolism of Rosuvastatin can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Rosuvastatin.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Rosuvastatin.
Dexamethasone Injection Dexamethasone Injection The metabolism of Rosuvastatin can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Rosuvastatin.
Venetoclax Venetoclax The metabolism of Rosuvastatin can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Rosuvastatin can be decreased when combined with Cobicistat.
Selexipag Selexipag The excretion of Selexipag can be decreased when combined with Rosuvastatin.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Rosuvastatin can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection The excretion of Rosuvastatin can be decreased when combined with Furosemide.
Rucaparib Rucaparib Rucaparib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Rosuvastatin.
Ribociclib Ribociclib The metabolism of Rosuvastatin can be decreased when combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Rosuvastatin can be decreased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Rosuvastatin.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be decreased when combined with Rosuvastatin.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Rosuvastatin.
Deflazacort Deflazacort The metabolism of Rosuvastatin can be increased when combined with Deflazacort.
Safinamide Safinamide Safinamide may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Rosuvastatin.
Sarilumab Injection Sarilumab Injection The metabolism of Rosuvastatin can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Rosuvastatin can be increased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Rosuvastatin.
Enasidenib Enasidenib The metabolism of Rosuvastatin can be decreased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Rosuvastatin can be increased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Rosuvastatin.
Delafloxacin Delafloxacin The metabolism of Rosuvastatin can be increased when combined with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Rosuvastatin can be decreased when combined with Abemaciclib.
Acalabrutinib Acalabrutinib The metabolism of Rosuvastatin can be decreased when combined with Acalabrutinib.
Letermovir Letermovir Letermovir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Rosuvastatin.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Rosuvastatin.
Buprenorphine Injection Buprenorphine Injection Buprenorphine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Apalutamide Apalutamide The metabolism of Rosuvastatin can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Rosuvastatin.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Baricitinib Baricitinib The metabolism of Rosuvastatin can be decreased when combined with Baricitinib.
Ivosidenib Ivosidenib The metabolism of Rosuvastatin can be decreased when combined with Ivosidenib.
Elagolix Elagolix The excretion of Elagolix can be decreased when combined with Rosuvastatin.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Rosuvastatin.
Cannabidiol Cannabidiol Cannabidiol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Dacomitinib Dacomitinib The metabolism of Rosuvastatin can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Rosuvastatin.
Stiripentol Stiripentol The metabolism of Rosuvastatin can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Glasdegib Glasdegib Glasdegib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Rosuvastatin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Rosuvastatin.
Rifamycin Rifamycin The metabolism of Rosuvastatin can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Rosuvastatin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Rosuvastatin can be increased when combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Rosuvastatin.
Acyclovir Ophthalmic Acyclovir Ophthalmic The excretion of Rosuvastatin can be decreased when combined with Acyclovir.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Rosuvastatin.
Esomeprazole Injection Esomeprazole Injection The excretion of Rosuvastatin can be decreased when combined with Esomeprazole.
Alpelisib Alpelisib The serum concentration of Rosuvastatin can be decreased when it is combined with Alpelisib.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Rosuvastatin.
Darolutamide Darolutamide The serum concentration of Rosuvastatin can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Rosuvastatin can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Rosuvastatin.
Pexidartinib Pexidartinib The metabolism of Rosuvastatin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline Rosuvastatin may decrease the excretion rate of Istradefylline which could result in a higher serum level.
Pitolisant Pitolisant The serum concentration of Rosuvastatin can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Lefamulin Lefamulin The metabolism of Lefamulin can be decreased when combined with Rosuvastatin.
Phenytoin Injection Phenytoin Injection The metabolism of Rosuvastatin can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Rosuvastatin can be increased when combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Rosuvastatin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Rosuvastatin.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Rosuvastatin.
Lasmiditan Lasmiditan The serum concentration of Rosuvastatin can be increased when it is combined with Lasmiditan.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Rosuvastatin.
Bempedoic Acid Bempedoic Acid The excretion of Rosuvastatin can be decreased when combined with Bempedoic acid.
Cenobamate Cenobamate The serum concentration of Rosuvastatin can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Rosuvastatin.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Rosuvastatin.
Remdesivir Injection Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Rosuvastatin.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Capmatinib Capmatinib The serum concentration of Rosuvastatin can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Rosuvastatin.
Fostemsavir Fostemsavir The serum concentration of Rosuvastatin can be increased when it is combined with Fostemsavir.
Octreotide Octreotide The metabolism of Rosuvastatin can be decreased when combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Rosuvastatin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Rosuvastatin can be decreased when it is combined with Satralizumab.
Cabotegravir Cabotegravir The excretion of Rosuvastatin can be decreased when combined with Cabotegravir.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Rosuvastatin may decrease the excretion rate of Drospirenone which could result in a higher serum level.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Rosuvastatin can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Rosuvastatin.
Indomethacin Indomethacin The excretion of Rosuvastatin can be decreased when combined with Indomethacin.
Mefenamic Acid Mefenamic Acid The metabolism of Rosuvastatin can be decreased when combined with Mefenamic acid.
Naproxen Naproxen Naproxen may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Trazodone Trazodone The metabolism of Rosuvastatin can be decreased when combined with Trazodone.
Isotretinoin Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Rosuvastatin.
Sodium Bicarbonate Sodium Bicarbonate Sodium bicarbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxuridine Floxuridine The metabolism of Rosuvastatin can be decreased when combined with Floxuridine.
Phenobarbital Phenobarbital The metabolism of Rosuvastatin can be decreased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Methotrexate.
Primidone Primidone The metabolism of Rosuvastatin can be increased when combined with Primidone.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Diazepam Diazepam The metabolism of Rosuvastatin can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Rosuvastatin can be decreased when combined with Lorazepam.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Rosuvastatin.
Tranylcypromine Tranylcypromine The metabolism of Rosuvastatin can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Rosuvastatin can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Procarbazine.
Tetracycline Tetracycline The excretion of Rosuvastatin can be decreased when combined with Tetracycline.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Rosuvastatin.
Prochlorperazine Prochlorperazine The metabolism of Rosuvastatin can be decreased when combined with Prochlorperazine.
Dapsone Dapsone The metabolism of Rosuvastatin can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Rosuvastatin can be increased when used in combination with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Rosuvastatin can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Rosuvastatin can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Rosuvastatin can be decreased when combined with Oxybutynin.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ibuprofen Ibuprofen The excretion of Rosuvastatin can be decreased when combined with Ibuprofen.
Orphenadrine Orphenadrine The metabolism of Orphenadrine can be decreased when combined with Rosuvastatin.
Phentermine Phentermine The metabolism of Rosuvastatin can be decreased when combined with Phentermine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Hydrocortisone Hydrocortisone The metabolism of Rosuvastatin can be increased when combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Rosuvastatin can be decreased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Rosuvastatin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Rosuvastatin.
Methyldopa Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Rosuvastatin.
Clonidine Clonidine The metabolism of Rosuvastatin can be decreased when combined with Clonidine.
Hydralazine Hydralazine The metabolism of Rosuvastatin can be decreased when combined with Hydralazine.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Rosuvastatin.
Loperamide Loperamide The metabolism of Rosuvastatin can be decreased when combined with Loperamide.
Promethazine Promethazine The metabolism of Rosuvastatin can be decreased when combined with Promethazine.
Daunorubicin Daunorubicin Daunorubicin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Rosuvastatin can be increased when combined with Griseofulvin.
Digoxin Digoxin Rosuvastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Rosuvastatin.
Quinine Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Rosuvastatin.
Calcitriol Calcitriol The metabolism of Rosuvastatin can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Rosuvastatin can be decreased when combined with Sulfinpyrazone.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Rosuvastatin.
Secobarbital Secobarbital The metabolism of Rosuvastatin can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Rosuvastatin can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Rosuvastatin can be decreased when combined with Amitriptyline.
Probenecid Probenecid The excretion of Rosuvastatin can be decreased when combined with Probenecid.
Quinidine Quinidine The metabolism of Rosuvastatin can be decreased when combined with Quinidine.
Procainamide Procainamide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procainamide is combined with Rosuvastatin.
Isoniazid Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Rosuvastatin.
Rifampin Rifampin The metabolism of Rifampicin can be increased when combined with Rosuvastatin.
Disopyramide Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Rosuvastatin.
Valproic Acid Valproic Acid The excretion of Rosuvastatin can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Rosuvastatin can be decreased when combined with Tamoxifen.
Liothyronine Liothyronine The excretion of Rosuvastatin can be decreased when combined with Liothyronine.
Methimazole Methimazole The metabolism of Rosuvastatin can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Rosuvastatin.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Rosuvastatin.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Rosuvastatin.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Rosuvastatin.
Dextromethorphan Dextromethorphan The metabolism of Rosuvastatin can be decreased when combined with Dextromethorphan.
Dinoprostone Dinoprostone The excretion of Rosuvastatin can be decreased when combined with Dinoprostone.
Niacin Niacin The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Rosuvastatin.
Baclofen Baclofen The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Rosuvastatin.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be decreased when combined with Rosuvastatin.
Hydrochlorothiazide Hydrochlorothiazide The excretion of Hydrochlorothiazide can be decreased when combined with Rosuvastatin.
Danazol Danazol The serum concentration of Rosuvastatin can be increased when it is combined with Danazol.
Disulfiram Disulfiram Disulfiram may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Rosuvastatin can be decreased when combined with Propranolol.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Rosuvastatin.
Spironolactone Spironolactone Spironolactone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Amphotericin B Injection Amphotericin B Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Rosuvastatin.
Mercaptopurine Mercaptopurine The excretion of Rosuvastatin can be decreased when combined with Mercaptopurine.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol The excretion of Allopurinol can be decreased when combined with Rosuvastatin.
Fluorouracil Injection Fluorouracil Injection The metabolism of Rosuvastatin can be decreased when combined with Fluorouracil.
Colchicine Colchicine Rosuvastatin may increase the myopathic rhabdomyolysis activities of Colchicine.
Cefaclor Cefaclor The excretion of Rosuvastatin can be decreased when combined with Cefaclor.
Cefadroxil Cefadroxil The excretion of Rosuvastatin can be decreased when combined with Cefadroxil.
Cefazolin Injection Cefazolin Injection The excretion of Cefazolin can be decreased when combined with Rosuvastatin.
Cephalexin Cephalexin The excretion of Rosuvastatin can be decreased when combined with Cephalexin.
Acetazolamide Acetazolamide The metabolism of Rosuvastatin can be decreased when combined with Acetazolamide.
Nystatin Nystatin The excretion of Rosuvastatin can be decreased when combined with Nystatin.
Cefotaxime Injection Cefotaxime Injection The excretion of Rosuvastatin can be decreased when combined with Cefotaxime.
Ketoconazole Ketoconazole The metabolism of Rosuvastatin can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Rosuvastatin.
Vincristine Injection Vincristine Injection The metabolism of Rosuvastatin can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Vinblastine Vinblastine The metabolism of Rosuvastatin can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Rosuvastatin can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The metabolism of Rosuvastatin can be decreased when combined with Hydroxyzine.
Aspirin Aspirin The excretion of Rosuvastatin can be decreased when combined with Acetylsalicylic acid.
Alprazolam Alprazolam The metabolism of Rosuvastatin can be decreased when combined with Alprazolam.
Triazolam Triazolam The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Rosuvastatin.
Trimethoprim Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Rosuvastatin.
Diltiazem Diltiazem The metabolism of Rosuvastatin can be decreased when combined with Diltiazem.
Nifedipine Nifedipine Nifedipine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Verapamil Verapamil The metabolism of Rosuvastatin can be decreased when combined with Verapamil.
Atenolol Atenolol Atenolol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The metabolism of Rosuvastatin can be decreased when combined with Cisplatin.
Piroxicam Piroxicam The excretion of Rosuvastatin can be decreased when combined with Piroxicam.
Bumetanide Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Rosuvastatin.
Etoposide Etoposide The metabolism of Rosuvastatin can be decreased when combined with Etoposide.
Glyburide Glyburide Glyburide may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Rosuvastatin.
Dicloxacillin Dicloxacillin The metabolism of Rosuvastatin can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Rosuvastatin can be increased when combined with Nafcillin.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Rosuvastatin.
Ceftriaxone Injection Ceftriaxone Injection The excretion of Rosuvastatin can be decreased when combined with Ceftriaxone.
Leuprolide Injection Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Rosuvastatin.
Gemfibrozil Gemfibrozil The serum concentration of Rosuvastatin can be increased when it is combined with Gemfibrozil.
Ketoprofen Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Rosuvastatin.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Rosuvastatin.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Rosuvastatin.
Flurbiprofen Flurbiprofen The metabolism of Rosuvastatin can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The metabolism of Rosuvastatin can be increased when combined with Amiodarone.
Buspirone Buspirone The metabolism of Rosuvastatin can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Rosuvastatin can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Rosuvastatin.
Diclofenac Diclofenac The excretion of Rosuvastatin can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine The metabolism of Rosuvastatin can be decreased when combined with Fluoxetine.
Clozapine Clozapine The metabolism of Rosuvastatin can be decreased when combined with Clozapine.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Rosuvastatin.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Ofloxacin.
Clarithromycin Clarithromycin The metabolism of Rosuvastatin can be decreased when combined with Clarithromycin.
Etodolac Etodolac The metabolism of Rosuvastatin can be decreased when combined with Etodolac.
Felodipine Felodipine The metabolism of Rosuvastatin can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Rosuvastatin can be decreased when combined with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Quinapril Quinapril The excretion of Quinapril can be decreased when combined with Rosuvastatin.
Simvastatin Simvastatin The metabolism of Rosuvastatin can be decreased when combined with Simvastatin.
Teniposide Injection Teniposide Injection The metabolism of Rosuvastatin can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Rosuvastatin can be decreased when combined with Itraconazole.
Atovaquone Atovaquone The metabolism of Rosuvastatin can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The metabolism of Rosuvastatin can be increased when combined with Rifabutin.
Zolpidem Zolpidem The metabolism of Rosuvastatin can be decreased when combined with Zolpidem.
Doxazosin Doxazosin The metabolism of Rosuvastatin can be decreased when combined with Doxazosin.
Isradipine Isradipine The metabolism of Rosuvastatin can be decreased when combined with Isradipine.
Omeprazole Omeprazole Omeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Cisapride Cisapride The metabolism of Rosuvastatin can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fluvastatin is combined with Rosuvastatin.
Venlafaxine Venlafaxine The metabolism of Rosuvastatin can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Rosuvastatin.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Rosuvastatin.
Famciclovir Famciclovir The metabolism of Rosuvastatin can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Rosuvastatin can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Rosuvastatin can be decreased when combined with Nefazodone.
Losartan Losartan The metabolism of Rosuvastatin can be decreased when combined with Losartan.
Valacyclovir Valacyclovir The excretion of Valaciclovir can be decreased when combined with Rosuvastatin.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Rosuvastatin.
Lansoprazole Lansoprazole Lansoprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Rosuvastatin.
Ifosfamide Injection Ifosfamide Injection The metabolism of Rosuvastatin can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The metabolism of Rosuvastatin can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Bupropion can be decreased when combined with Rosuvastatin.
Ticlopidine Ticlopidine The metabolism of Rosuvastatin can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Rosuvastatin.
Metformin Metformin Metformin may increase the hypolipidaemic activities of Rosuvastatin.
Nisoldipine Nisoldipine The metabolism of Rosuvastatin can be decreased when combined with Nisoldipine.
Lamivudine Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Rosuvastatin.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Rosuvastatin.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Rosuvastatin.
Indinavir Indinavir Indinavir may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Rosuvastatin can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Rosuvastatin.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Rosuvastatin.
Zafirlukast Zafirlukast The metabolism of Rosuvastatin can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Rosuvastatin can be decreased when combined with Mirtazapine.
Topiramate Topiramate The metabolism of Rosuvastatin can be increased when combined with Topiramate.
Zileuton Zileuton The metabolism of Rosuvastatin can be decreased when combined with Zileuton.
Valsartan Valsartan The metabolism of Rosuvastatin can be decreased when combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosuvastatin.
Donepezil Donepezil The metabolism of Rosuvastatin can be decreased when combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Rosuvastatin can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The excretion of Fexofenadine can be decreased when combined with Rosuvastatin.
Azithromycin Azithromycin The metabolism of Rosuvastatin can be decreased when combined with Azithromycin.
Loratadine Loratadine Loratadine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Rosuvastatin.
Nilutamide Nilutamide The metabolism of Rosuvastatin can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Rosuvastatin can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Rosuvastatin can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Rosuvastatin can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Rosuvastatin can be decreased when combined with Sertraline.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Rosuvastatin.
Raloxifene Raloxifene The metabolism of Rosuvastatin can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Rosuvastatin can be decreased when combined with Irbesartan.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Rosuvastatin.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Rosuvastatin.
Paroxetine Paroxetine The metabolism of Rosuvastatin can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The metabolism of Rosuvastatin can be decreased when combined with Tolcapone.
Citalopram Citalopram The metabolism of Rosuvastatin can be decreased when combined with Citalopram.
Capecitabine Capecitabine The metabolism of Rosuvastatin can be decreased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Rosuvastatin can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Rosuvastatin.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Rosuvastatin.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Rosuvastatin.
Tolterodine Tolterodine The metabolism of Rosuvastatin can be decreased when combined with Tolterodine.
Thalidomide Thalidomide The metabolism of Rosuvastatin can be increased when combined with Thalidomide.
Oseltamivir Oseltamivir The excretion of Oseltamivir can be decreased when combined with Rosuvastatin.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Rosuvastatin.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Rosuvastatin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists